The Effect of Education Given to Hemodialysis Patients With Pecha Kuka Method on Attitude Towards Diet Therapy and Compliance With Fluid Restriction

February 21, 2026 updated by: Gülcan Bahçecioğlu Turan, Ataturk University

Hemodialysis complex treatment regimen includes fluid and diet management. In this context, it is recommended that patients choose foods with low sodium, potassium and phosphorus content, maintain adequate protein intake, and regulate their daily fluid intake not exceeding 1-2 liters. In maintaining the health of hemodialysis patients; It is very important that they comply with the treatment program, diet and fluid restrictions. As the life expectancy increases, the time spent with chronic disease also increases, and both the patient himself and his relatives living in the same house are faced with this chronic disease and accompanying stress factors for a longer period of time, making it difficult for them to adapt to the progression of the disease.

Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. When the literature was examined, no study was found that evaluated the effect of the education given to hemodialysis patients with the Pecha Kuka method on the attitude towards diet therapy and compliance with fluid restriction. In addition, it is thought that this short and concise education method will contribute to a better understanding of the attitudes of patients receiving hemodialysis treatment towards diet therapy and their compliance with fluid restriction, thus providing important data for future studies.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Diet is one of the most important elements of HD treatment. Kidney disease can be slowed down with diet. There are important issues in the diet of individuals receiving HD treatment. Adequate energy consumption comes first. Individuals receiving HD treatment must meet the energy requirements needed to maintain their health, as well as perform their metabolic functions. Adequate protein intake is one of the important issues in the diet in patients receiving HD treatment. Compliance with disease treatment; it is briefly defined as "individual compliance with medical treatment and health recommendations". During the period of hemodialysis treatment, one of the areas where individuals have difficulty in adapting is diet and fluid restriction. Because the disease and HD treatment directly affect the eating habits and preferences of individuals. As with all chronic diseases, it is very important for individuals who continue HD treatment to comply with the drug treatment program, diet and fluid restrictions in order to maintain their health. refers to a fast and concise presentation format. It was created in 2003 by architects Astrid Klein and Mark Dytham, who hoped to give young designers the opportunity to present their work in a short, fast-paced setting. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and there is little text on the slides.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Elâzığ, Merkez, Turkey (Türkiye), 23000
        • Gülcan B Turan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The patient does not have any impairment (such as vision, speech and hearing) that prevents him from communicating.
  • Accepting the research
  • Being receiving hemodialysis treatment
  • Ability to communicate adequately
  • Absence of psychiatric problems

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Routine maintenance will be applied.
Experimental: Experimental:
pecha kucha will be practiced
pecha kucha training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitude Scale Towards Dietary Treatment of Hemodialysis Patients
Time Frame: 1 hours later

"Attitude Scale Towards Dietary Treatment of Hemodialysis Patients" is a 16-item scale developed by Onbe and Kanda in 2018 to determine the attitudes of patients towards diet therapy. It is a 4 likert scale.

Each item represents 1-Strongly agree, 2-Agree, 3-Disagree, 4-Strongly Disagree. This scale consists of 3 sub-dimensions.

  1. Sub size; "Behavioral tendency affected by cognition" includes 7 items (1,2,3,4,5,6,7).
  2. Sub-dimension; "Behavioral tendency affected by food culture" includes 6 (8,9,10,11,12,13) items.
  3. Sub-dimension; "Negative effect that changes diet" includes 3 items (14,15,16). The last three items in the scale are reversed.

Higher scores obtained from the scale indicate that attitudes are better. Effect on Retention and Fluid Restriction Compliance

1 hours later
Dialysis Diet and Fluid Restriction Compliance Scale
Time Frame: 1 hours later
It was developed by Vlaminck et al. (2001), and its Turkish validity and reliability study was performed by Kara (2009) in hemodialysis patients. WHO is a four-item self-report tool used to evaluate non-adherence to diet and fluid intake restriction in hemodialysis patients. Two items in the scale deal with diet (items 1 and 2), and the other two deal with fluid restriction (items 3 and 4) in terms of frequency and degree. The frequency of non-compliance with diet and fluid restriction is based on the behaviors of the patients in the previous 14 days. The degree of non-compliance with diet and fluid restriction has a Likert-type structure scored between 0-4 (No non-compliance = 0, Mild = 1, Moderate = 2, Severe = 3, Very severe =4) The Cronbach alpha coefficient of the scale was reported as 0.70.
1 hours later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

November 1, 2025

Study Registration Dates

First Submitted

April 12, 2023

First Submitted That Met QC Criteria

May 10, 2023

First Posted (Actual)

May 22, 2023

Study Record Updates

Last Update Posted (Actual)

February 24, 2026

Last Update Submitted That Met QC Criteria

February 21, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2023/ 04- 12

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis Patients

Clinical Trials on pecha kucha

Subscribe